Inventor · disambiguated record
Tho V. Thieu
Also filed as: THIEU THO · THIEU THO V
6 granted patents·4 pending applications·30 citations·filing 2005–2024
76Inventor score
Top patents by PatentIndex Score
10 records- 0189US8148391B2Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitorsAHMED GULZAR·Filed 2007·Granted Apr 3, 2012·17 cites·8 claims
- 0285US8552186B2Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitorsAHMED GULZAR·Filed 2012·Granted Oct 8, 2013·10 cites·26 claims
- 0373US8471005B2Pyrrolotriazines as ALK and JAK2 inhibitorsBRESLIN HENRY J·Filed 2011·Granted Jun 25, 2013·3 cites·10 claims
- 0473US2024228465A1Substituted pyridine n-oxide derivatives useful as a factor xia inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0567US11919881B2Substituted pyridine N-oxide derivatives useful as a factor XIa inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Mar 5, 2024·0 cites·9 claims
- 0663US2024279281A1Peptide Inhibitors of Interleukin-23 ReceptorJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0762US2023295157A13-(1h-imidazol-2-yl)-2,3,8,8a-tetrahydroindolizin-5(1h)-one derivatives useful as factor xia inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0858US2023097157A1Bicyclic Pyridin-2-one and pyrimidin-4-one Derivatives Useful As a Factor XIa InhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0955US11814364B2Pyridine N-oxide derivatives useful as factor XIa inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Nov 14, 2023·0 cites·10 claims
- 1046US7446210B2Factor Xa compoundsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Nov 4, 2008·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Tho V. Thieu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →